Society of Gynecologic Oncology Publications
- The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing elective surgical procedures and proceeding cautiously with cancer procedures that may require significant hospital resources and expose vulnerable patients to the virus. These challenges have particularly distressing for women with a gynecologic cancer diagnosis and their providers.
- The total cost of cancer care in the United States continues to rise and is estimated to range from 172 to 206 billion dollars per year by 2020 . This has important implications for our healthcare system's sustainability as well as for cancer patients who are at increased risk for experiencing significant financial strain due to out-of-pocket costs [1–3]. The National Academy of Medicine (formerly Institute of Medicine) endorses efforts to “improve the affordability of cancer care by leveraging existing efforts to reform payment and eliminate waste” .
- The practice of gynecologic oncology is facing significant changes in reimbursement practices and health care delivery in the United States. As the only physicians trained to provide both complex surgical and medical treatment for women with gynecologic cancers, gynecologic oncologists are the ideal leaders for developing best practice models and outcome measures for women with gynecologic cancers. The Society of Gynecologic Oncology (SGO) created the Health Policy and SocioEconomic Committee (HPSC) in 2015 to spearhead society-based efforts to ensure leadership and participation in navigating this era of health care reform.